Kaplan Fox

ChargePoint (CHPT) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds ChargePoint Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Wednesday, January 17, 2024
Notice, Kaplan Fox, FOX, GAAP, ChargePoint, Complaint, News

NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired ChargePoint Holdings, Inc. (“ChargePoint” or the “Company”) (NYSE: CHPT) securities between June 1, 2023 and November 16, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired ChargePoint Holdings, Inc. (“ChargePoint” or the “Company”) (NYSE: CHPT) securities between June 1, 2023 and November 16, 2023, inclusive (the “Class Period”).
  • If you acquired ChargePoint securities during the Class Period and would like to discuss this case, please click here .
  • WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.
  • For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .

EGRX Investor Update: Kaplan Fox & Kilsheimer LLP Notifies Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline

Retrieved on: 
Wednesday, January 17, 2024
Kaplan Fox, Complaint, FOX, News, Cryptocurrency

NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) securities between August 8, 2023 and November 28, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) securities between August 8, 2023 and November 28, 2023, inclusive (the “Class Period”).
  • If you purchased Eagle securities during the Class Period and would like to discuss our investigation, your rights, or your interests please click here .
  • WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.
  • For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .

LivePerson (LPSN) Investor Alert: Kaplan Fox & Kilsheimer LLP Reminds LivePerson Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Wednesday, January 17, 2024
Notice, Annual report, Medicare, LPSN, Kaplan Fox, FOX, LivePerson, Complaint, News, Cryptocurrency

NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors who purchased or otherwise acquired LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) securities between May 10, 2022 and March 16, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors who purchased or otherwise acquired LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) securities between May 10, 2022 and March 16, 2023, inclusive (the “Class Period”).
  • If you acquired LivePerson securities during the Class Period and would like to discuss this case, please click here .
  • With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.
  • For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .

Inspire Medical (INSP) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Wednesday, January 17, 2024
Notice, Patient, INSP, Obstructive sleep apnea, Kaplan Fox, FOX, Acceleration, Medicine, Complaint, News, Pharmaceutical industry

Inspire Medical (INSP) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline

Key Points: 
  • Inspire Medical (INSP) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline
    The issuer is solely responsible for the content of this announcement.
  • NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).
  • If you acquired Inspire Medical common stock during the Class Period and would like to discuss this case, please click here .
  • Inspire Medical is a medical technology company that develops and commercializes minimally invasive products for patients with obstructive sleep apnea (“OSA”) that require prior authorizations from doctors.

Driven Brands (DRVN) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Wednesday, January 17, 2024
Notice, Glass, Car wash, Kaplan Fox, FOX, DRVN, Windshield, Complaint, News

Driven Brands (DRVN) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

Key Points: 
  • Driven Brands (DRVN) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline
    The issuer is solely responsible for the content of this announcement.
  • NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Driven Brands Holdings, Inc. (“Driven Brands” or the “Company”) (NASDAQ: DRVN) between October 27, 2021 and August 1, 2023, inclusive (the “Class Period”).
  • If you acquired Driven Brands common stock during the Class Period and would like to discuss this case, please click here .
  • For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .

Acelyrin (SLRN) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds Acelyrin Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Wednesday, January 17, 2024
Patient, Part, SLRN, Kaplan Fox, Complaint, HS, FOX, Abscess, News

NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Acelyrin, Inc. (“Acelyrin” or the “Company”) (NASDAQ: SLRN) securities between May 4, 2023 and September 11, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW YORK, NY - ( NewMediaWire ) - January 16, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Acelyrin, Inc. (“Acelyrin” or the “Company”) (NASDAQ: SLRN) securities between May 4, 2023 and September 11, 2023, inclusive (the “Class Period”).
  • If you purchased Acelyrin securities and would like to discuss this notice, your rights, or your interests please click here .
  • WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.
  • For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .

MBLY Investor Alert: Kaplan Fox & Kilsheimer LLP is Investigating Securities Fraud Claims Against Mobileye Global Inc.

Retrieved on: 
Wednesday, January 17, 2024
Kaplan Fox, FOX, News, Mobileye

MBLY Investor Alert: Kaplan Fox & Kilsheimer LLP is Investigating Securities Fraud Claims Against Mobileye Global Inc.

Key Points: 
  • MBLY Investor Alert: Kaplan Fox & Kilsheimer LLP is Investigating Securities Fraud Claims Against Mobileye Global Inc.
  • MBLY Investor Alert: Kaplan Fox & Kilsheimer LLP is Investigating Securities Fraud Claims Against Mobileye Global Inc.
    NEW YORK, NY - ( NewMediaWire ) - January 12, 2024 - Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating claims on behalf of investors of Mobileye Global Inc. (“Mobileye” or the “Company”) (NASDAQ: MBLY).
  • WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.
  • With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.

DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Thursday, January 4, 2024
FOX, Car wash, Complaint, Notice, Glass, News, Windshield, DRVN, Kaplan Fox

NEW YORK, NY – January 4, 2024 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Driven Brands Holdings, Inc. (“Driven Brands” or the “Company”) (NASDAQ: DRVN) between October 27, 2021 and August 1, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW YORK, NY – January 4, 2024 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Driven Brands Holdings, Inc. (“Driven Brands” or the “Company”) (NASDAQ: DRVN) between October 27, 2021 and August 1, 2023, inclusive (the “Class Period”).
  • If you acquired Driven Brands common stock during the Class Period and would like to discuss this case, please click here .
  • WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.
  • For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .

INSPIRE MEDICAL INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Thursday, January 4, 2024
FOX, Obstructive sleep apnea, Acceleration, Complaint, Notice, News, Patient, Kaplan Fox, Pharmaceutical industry

NEW YORK, NY – January 4, 2024 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).

Key Points: 
  • NEW YORK, NY – January 4, 2024 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) common stock between May 3, 2023 and November 7, 2023, inclusive (the “Class Period”).
  • If you acquired Inspire Medical common stock during the Class Period and would like to discuss this case, please click here .
  • Inspire Medical is a medical technology company that develops and commercializes minimally invasive products for patients with obstructive sleep apnea (“OSA”) that require prior authorizations from doctors.
  • For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .

Kaplan Fox & Kilsheimer LLP Reminds Mercury Systems, Inc. (MRCY) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Saturday, December 30, 2023
FOX, Failure, Glass house, Sale, Acquisition, Mercury, Mercury Systems, Complaint, Notice, News, IMPACT, MRCY, Kaplan Fox, Cryptocurrency

If you acquired Mercury common stock and would like to discuss this case, please click here .

Key Points: 
  • If you acquired Mercury common stock and would like to discuss this case, please click here .
  • WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.
  • With over 50 years of experience in complex litigation, Kaplan Fox offers the professional experience and track record that clients demand.
  • For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com .